T44.7X Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists

Name of the Condition

• Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists
• This code covers conditions resulting from exposure to beta-adrenoreceptor antagonists (beta-blockers), including toxic effects, adverse reactions, or insufficient dosing.

Summary

This category includes poisoning, adverse effects, or underdosing related to beta-adrenoreceptor antagonists, which are medications used to manage cardiovascular conditions like hypertension, arrhythmias, and heart failure. The code encompasses scenarios where these drugs cause harm or fail to achieve therapeutic effects.

Causes

Poisoning or adverse effects may result from accidental or intentional overdose, incorrect administration, or interactions with other substances. Underdosing occurs when a patient receives insufficient medication to achieve the intended therapeutic effect, potentially due to dosing errors or non-adherence.

Risk Factors

• Concurrent use of multiple medications affecting cardiovascular function.
• Pre-existing conditions that alter drug metabolism or sensitivity (e.g., asthma, diabetes).
• Age-related changes in drug response (e.g., elderly or pediatric patients).
• History of substance use or misuse.

Symptoms

• Bradycardia (slow heart rate) or tachycardia (fast heart rate).
• Fatigue, dizziness, or hypotension.
• Cold extremities or Raynaud’s phenomenon.
• Difficulty breathing or wheezing.
• Depression, mood changes, or cognitive impairment.
• Hypoglycemia (especially in diabetic patients).

Diagnosis

Assessment of symptoms following beta-blocker exposure. Review of patient’s medical history for allergies, pre-existing conditions, or medication interactions. Monitoring vital signs, EKG, and blood glucose levels. Toxicology screening if overdose is suspected.

Treatment Options

• Discontinuation or dose adjustment of the beta-blocker.
• Supportive care (e.g., IV fluids, oxygen) for severe symptoms.
• Antidotes (e.g., glucagon) for beta-blocker overdose.
• Management of specific complications (e.g., bronchodilators for asthma).

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Most adverse effects resolve with dose adjustment or discontinuation. Underdosing may require re-evaluation of therapy. Follow-up includes monitoring for recurrence and adjusting treatment as needed.

Complications

• Severe bradycardia or heart block.
• Worsening of asthma or chronic obstructive pulmonary disease (COPD).
• Hypoglycemia with impaired awareness.
• Depression or cognitive decline with long-term use.

Lifestyle & Prevention

• Adhere to prescribed dosing and avoid abrupt discontinuation.
• Inform healthcare providers of all medications, including over-the-counter drugs.
• Monitor for symptoms and report changes promptly.
• Avoid alcohol or substances that may interact with beta-blockers.

When to Seek Professional Help

Seek immediate care for chest pain, severe dizziness, difficulty breathing, or signs of overdose (e.g., confusion, seizures). Contact a provider for persistent or worsening symptoms.

Tips for Medical Coders

• Use this code for poisoning, adverse effects, or underdosing of beta-adrenoreceptor antagonists.
• Document the encounter type (e.g., initial, subsequent) and specify if the event is accidental, intentional, or therapeutic.
• Include details on the specific beta-blocker involved and the clinical context (e.g., overdose, underdosing, adverse reaction).